Výsledky vyhledávání - "Trisha Govender"

The Outcome and Safety of Re-challenge Lutetium-177 PSMA (177Lu-PSMA) Therapy with Low-Dose Docetaxel as a Radiosensitizer—a Promising Combination in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): a Case Report

Autor: Aviral Singh, Nisaar Korowlay, Lucille Heslop, Masha Maharaj, Trisha Govender, Mike Sathekge, Partha Choudhary

Publikováno v: Nucl Med Mol Imaging

Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (PSMA-RLT) with lutetium-177 ((177)Lu-PSMA) has been used in metastatic castrate-resistant prostate cancer (mCRPC), and retrospective data have shown this therapy to be favourably

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::786e14c67f0cd2b73c26c2560d365e0d
https://doi.org/10.1007/s13139-021-00696-5

Zobrazit plný text záznamu

Exceptional Response of Rare Plasmacytoid Variant Prostate Cancer Post 177Lu-PSMA Therapy Seen on 68Ga-PSMA PET/CT

Autor: Masha, Maharaj, Lucille, Heslop, Trisha, Govender, Nisaar, Korowlay

Publikováno v: Clinical Nuclear Medicine. 48:e69-e70

Plasmacytoid is a rare variant of acinar prostatic adenocarcinoma. The aggressive type is characterized by an aggressive clinical course, lack of responsiveness to hormonal therapies, and an overall poor prognosis. Here we present pretherapy and post

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a7358bb5a7a5f7dc3fb984418393ae9
https://doi.org/10.1097/rlu.0000000000004473

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání